Cellectis SA (CLLS)
1.61
+0.02
(+1.26%)
USD |
NASDAQ |
Dec 20, 16:00
1.58
-0.03
(-1.86%)
After-Hours: 20:00
Cellectis Market Cap: 161.15M for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Edap TMS SA | 81.63M |
| DBV Technologies SA | 65.45M |
| Genfit SA | 189.64M |
| Akari Therapeutics PLC | 24.02M |
| Biodexa Pharmaceuticals PLC | 2.265M |
Market Cap Related Metrics
| PS Ratio | 4.962 |
| Price to Book Value | 1.245 |
| Price to Free Cash Flow | 2.389 |
| Price | 1.61 |
| Earnings Yield | -83.23% |